Biofrontera Cash Flow | StatInvestor

Health Care & Life Sciences » Biotechnology | Biofrontera AG

Biofrontera AG | Cash Flow

Fiscal year is January-December. All values EUR Thousands.

2013

2014

2015

2016

2017

2018

Net Income before Extraordinaries

8,066.60

10,721.00

11,203.40

10,579.20

16,102.00

19,269

Depreciation, Depletion & Amortization

742.10

811.00

811.70

830.80

834.00

754

Other Funds

664.00

2,461

Funds from Operations

7,227.40

8,817.80

10,295.10

9,789.50

13,636.00

16,054

Changes in Working Capital

1,248.50

578.00

462.80

1,788.80

75.00

2,084

Net Operating Cash Flow

8,475.90

8,239.80

10,757.90

11,578.30

13,711.00

13,970

Capital Expenditures

342.00

164.10

180.30

484.50

397.00

Sale of Fixed Assets & Businesses

100.40

13.40

26.30

16.00

Net Investing Cash Flow

342.00

63.70

167.00

458.20

381.00

Issuance/Reduction of Debt, Net

860.30

46.50

61.20

993.10

10,713.00

Net Financing Cash Flow

8,385.20

13,879.40

6,374.70

23,203.40

10,049.00

Net Change in Cash

432.70

5,575.80

4,550.20

11,166.90

4,043.00

Free Cash Flow

8,817.90

8,403.90

10,912.40

12,062.80

14,108.00

Change in Capital Stock

7,524.90

13,832.90

6,313.50

24,196.60

About Biofrontera

View Profile

Address	Hemmelrather Weg 201 Leverkusen Nordrhein-Westfalen 51377 Germany
Employees	-
Website	http://biofrontera.com
Updated	07/08/2019
Biofrontera AG is a biopharmaceutical company, which engages in the development, sale, and distribution of dermatological drugs and medical cosmetics for the care, protection, and treatment of the skin. Its products are used for the treatment of chronic, antihistamine refractory urticaria, and migraine prophylaxis. The company was founded by Hermann Lübbert in 1997 and is headquartered in Leverkusen, Germany.